FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2018476477> ?p ?o ?g. }

• W2018476477 endingPage "1312" @default.
• W2018476477 startingPage "1306" @default.
• W2018476477 abstract "ObjectiveOur objective was to evaluate the outcomes of radiofrequency ablation for nonsurgical candidates with clinical stage I non–small cell lung cancer.MethodsThis study was carried out on 20 nonsurgical candidates (11 men and 9 women; mean age, 75.6 years) with clinical stage I (IA, n = 14; IB, n = 6) non–small cell lung cancer. All patients were deemed nonsurgical candidates because of poor pulmonary function (n = 7), poor cardiac function (n = 3), poor performance status (n = 4), or refusal to undergo surgery (n = 6). The mean long-axis tumor diameter was 2.4 cm. Twenty patients underwent 23 percutaneous ablation sessions, including 3 repeat sessions for the treatment of local progression. The outcomes of radiofrequency ablation were retrospectively evaluated.ResultsProcedural complications included pneumothorax (n = 13 [57%]) and pleural effusion (n = 4 [17%]). One case of pneumothorax required chest tube placement. The median follow-up period was 21.8 months. Local progression was observed in 7 (35%) patients a median of 9.0 months after the first session. The local control rates were 72% at 1 year, 63% at 2 years, and 63% at 3 years. The mean survival time was 42 months. The overall survivals and cancer-specific survivals were 90% and 100% at 1 year, 84% and 93% at 2 years, and 74% and 83% at 3 years, respectively.ConclusionsTreating clinical stage I non–small cell lung cancer with one or more radiofrequency ablation sessions provided promising outcomes in terms of survival, although the rate of local progression was relatively high. A prospective study with a larger population and longer follow-up is warranted. Our objective was to evaluate the outcomes of radiofrequency ablation for nonsurgical candidates with clinical stage I non–small cell lung cancer. This study was carried out on 20 nonsurgical candidates (11 men and 9 women; mean age, 75.6 years) with clinical stage I (IA, n = 14; IB, n = 6) non–small cell lung cancer. All patients were deemed nonsurgical candidates because of poor pulmonary function (n = 7), poor cardiac function (n = 3), poor performance status (n = 4), or refusal to undergo surgery (n = 6). The mean long-axis tumor diameter was 2.4 cm. Twenty patients underwent 23 percutaneous ablation sessions, including 3 repeat sessions for the treatment of local progression. The outcomes of radiofrequency ablation were retrospectively evaluated. Procedural complications included pneumothorax (n = 13 [57%]) and pleural effusion (n = 4 [17%]). One case of pneumothorax required chest tube placement. The median follow-up period was 21.8 months. Local progression was observed in 7 (35%) patients a median of 9.0 months after the first session. The local control rates were 72% at 1 year, 63% at 2 years, and 63% at 3 years. The mean survival time was 42 months. The overall survivals and cancer-specific survivals were 90% and 100% at 1 year, 84% and 93% at 2 years, and 74% and 83% at 3 years, respectively. Treating clinical stage I non–small cell lung cancer with one or more radiofrequency ablation sessions provided promising outcomes in terms of survival, although the rate of local progression was relatively high. A prospective study with a larger population and longer follow-up is warranted." @default.
• W2018476477 created "2016-06-24" @default.
• W2018476477 creator A5000048544 @default.
• W2018476477 creator A5031306165 @default.
• W2018476477 creator A5036546726 @default.
• W2018476477 creator A5039625098 @default.
• W2018476477 creator A5041061791 @default.
• W2018476477 creator A5041320707 @default.
• W2018476477 creator A5054277034 @default.
• W2018476477 creator A5054635895 @default.
• W2018476477 creator A5064419838 @default.
• W2018476477 creator A5071175870 @default.
• W2018476477 creator A5086387870 @default.
• W2018476477 date "2007-11-01" @default.
• W2018476477 modified "2023-10-10" @default.
• W2018476477 title "Percutaneous radiofrequency ablation for clinical stage I non–small cell lung cancer: Results in 20 nonsurgical candidates" @default.
• W2018476477 cites W1527031473 @default.
• W2018476477 cites W1969712381 @default.
• W2018476477 cites W1973870205 @default.
• W2018476477 cites W1977023484 @default.
• W2018476477 cites W1991345460 @default.
• W2018476477 cites W1991625282 @default.
• W2018476477 cites W2005842510 @default.
• W2018476477 cites W2012221431 @default.
• W2018476477 cites W2036951466 @default.
• W2018476477 cites W2037212067 @default.
• W2018476477 cites W2037949046 @default.
• W2018476477 cites W2041547867 @default.
• W2018476477 cites W2050811691 @default.
• W2018476477 cites W2057604474 @default.
• W2018476477 cites W2067637832 @default.
• W2018476477 cites W2077642996 @default.
• W2018476477 cites W2082202968 @default.
• W2018476477 cites W2087471659 @default.
• W2018476477 cites W2101073090 @default.
• W2018476477 cites W2104586111 @default.
• W2018476477 cites W2115055763 @default.
• W2018476477 cites W2128399613 @default.
• W2018476477 cites W2135663105 @default.
• W2018476477 cites W2140871000 @default.
• W2018476477 cites W2140996967 @default.
• W2018476477 cites W2154944093 @default.
• W2018476477 cites W2155669932 @default.
• W2018476477 cites W2157222268 @default.
• W2018476477 cites W2162997519 @default.
• W2018476477 doi "https://doi.org/10.1016/j.jtcvs.2007.07.013" @default.
• W2018476477 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17976467" @default.
• W2018476477 hasPublicationYear "2007" @default.
• W2018476477 type Work @default.
• W2018476477 sameAs 2018476477 @default.
• W2018476477 citedByCount "112" @default.
• W2018476477 countsByYear W20184764772012 @default.
• W2018476477 countsByYear W20184764772013 @default.
• W2018476477 countsByYear W20184764772014 @default.
• W2018476477 countsByYear W20184764772015 @default.
• W2018476477 countsByYear W20184764772016 @default.
• W2018476477 countsByYear W20184764772017 @default.
• W2018476477 countsByYear W20184764772018 @default.
• W2018476477 countsByYear W20184764772019 @default.
• W2018476477 countsByYear W20184764772020 @default.
• W2018476477 countsByYear W20184764772021 @default.
• W2018476477 countsByYear W20184764772022 @default.
• W2018476477 countsByYear W20184764772023 @default.
• W2018476477 crossrefType "journal-article" @default.
• W2018476477 hasAuthorship W2018476477A5000048544 @default.
• W2018476477 hasAuthorship W2018476477A5031306165 @default.
• W2018476477 hasAuthorship W2018476477A5036546726 @default.
• W2018476477 hasAuthorship W2018476477A5039625098 @default.
• W2018476477 hasAuthorship W2018476477A5041061791 @default.
• W2018476477 hasAuthorship W2018476477A5041320707 @default.
• W2018476477 hasAuthorship W2018476477A5054277034 @default.
• W2018476477 hasAuthorship W2018476477A5054635895 @default.
• W2018476477 hasAuthorship W2018476477A5064419838 @default.
• W2018476477 hasAuthorship W2018476477A5071175870 @default.
• W2018476477 hasAuthorship W2018476477A5086387870 @default.
• W2018476477 hasBestOaLocation W20184764771 @default.
• W2018476477 hasConcept C121608353 @default.
• W2018476477 hasConcept C126322002 @default.
• W2018476477 hasConcept C126838900 @default.
• W2018476477 hasConcept C141071460 @default.
• W2018476477 hasConcept C146357865 @default.
• W2018476477 hasConcept C151730666 @default.
• W2018476477 hasConcept C188816634 @default.
• W2018476477 hasConcept C2776256026 @default.
• W2018476477 hasConcept C2777377203 @default.
• W2018476477 hasConcept C2778329176 @default.
• W2018476477 hasConcept C2778902805 @default.
• W2018476477 hasConcept C2779634585 @default.
• W2018476477 hasConcept C2780813298 @default.
• W2018476477 hasConcept C71924100 @default.
• W2018476477 hasConcept C75603125 @default.
• W2018476477 hasConcept C86803240 @default.
• W2018476477 hasConceptScore W2018476477C121608353 @default.
• W2018476477 hasConceptScore W2018476477C126322002 @default.
• W2018476477 hasConceptScore W2018476477C126838900 @default.
• W2018476477 hasConceptScore W2018476477C141071460 @default.
• W2018476477 hasConceptScore W2018476477C146357865 @default.
• W2018476477 hasConceptScore W2018476477C151730666 @default.

• next